Revision of the ARRIVE guidelines: Rationale and scope

BMJ Open Science

Volumn 2, Issue 1, 2018, Pages

  Percie Du Sert, Nathalie ^a   Hurst, Viki ^a   Ahluwalia, Amrita ^b   Alam, Sabina ^c   Altman, Douglas G ^d   Avey, Marc T ^e   Baker, Monya ^f   Browne, William ^g   Clark, Alejandra ^h   Cuthill, Innes C ^g   Dirnagl, Ulrich ⁱ   Emerson, Michael ^j   Garner, Paul ^k   Howells, David W ^l   Karp, Natasha A ^m   MacCallum, Catriona J ⁿ   MacLeod, Malcolm ^o   Petersen, Ole ^p   Rawle, Frances ^q   Reynolds, Penny ^r   Rooney, Kieron ^s   Sena, Emily S ^o   Silberberg, Shai D ^t   Steckler, Thomas ^u   Würbel, Hanno ^v   Holgate, Stephen T ^w   more..

^a National Centre for the Replacement   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c F1000Research   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ICF   (Canada)

^f Nature   (United States)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h Plos One ^*  (United Kingdom)

ⁱ BERLIN INSTITUTE OF HEALTH   (Germany)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^l UNIVERSITY OF TASMANIA   (Australia)

^m Discovery Sciences   (United Kingdom)

ⁿ Hindawi Ltd   (United Kingdom)

^o UNIVERSITY OF EDINBURGH   (United Kingdom)

^p CARDIFF UNIVERSITY   (United Kingdom)

^q MEDICAL RESEARCH COUNCIL   (United Kingdom)

^r UNIVERSITY OF FLORIDA   (United States)

^s UNIVERSITY OF SYDNEY   (Australia)

^t NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^u JANSSEN RESEARCH FOUNDATION   (Belgium)

^v UNIVERSITY OF BERN   (Switzerland)

^w UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85058515198     PISSN: None     EISSN: 23988703     Source Type: Journal    
DOI: 10.1136/bmjos-2018-000002     Document Type: Review

References (23)

1. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature 2014;505:612-3. doi:10.1038/505612a
2. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 2014;383:267-76. doi:10.1016/S0140-6736(13)62228-X
3. Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010;8:e1000412. doi:10.1371/journal.pbio.1000412
4. NC3Rs. ARRIVE: Animal Research Reporting In Vivo Experiments. 2017https://www.nc3rs.org.uk/arrive-animal-research-reporting-vivo-experiments (accessed 14 Sep 2017).
5. Cressey D. UK funders demand strong statistics for animal studies. Nature 2015;520:271-2. doi:10.1038/520271a
6. Baker D, Lidster K, Sottomayor A, et al. Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol 2014;12:e1001756. doi:10.1371/journal.pbio.1001756
7. Flórez-Vargas O, Brass A, Karystianis G, et al. Bias in the reporting of sex and age in biomedical research on mouse models. Elife 2016;5. doi:10.7554/eLife.13615
8. SenaE. Impact of an Intervention to Improve Compliance with the ARRIVE Guidelines (IICARus) for the reporting of in vivo animal research. Eighth international congress on Peer Review and Scientific Publication. 2017https://www.pscp.tv/w/1YqJDRBOYWwKV
9. Avey MT, Moher D, Sullivan KJ, et al. The devil is in the details: incomplete reporting in preclinical animal research. PLoS One 2016;11:e0166733. doi:10.1371/journal.pone.0166733
10. Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217. doi:10.1371/journal.pmed.1000217
11. Eisenach JC, Warner DS, Houle TT. Reporting of preclinical research in anesthesiology: transparency and enforcement. Anesthesiology 2016;124:763-5. doi:10.1097/ALN.0000000000001044
12. McGrath JC, Curtis MJ. BJP is changing its requirements for scientific papers to increase transparency. Br J Pharmacol 2015;172:2671-4. doi:10.1111/bph.12954
13. Bahor Z, Liao J, Macleod MR, et al. Risk of bias reporting in the recent animal focal cerebral ischaemia literature. Clin Sci 2017;131:2525-32. doi:10.1042/CS20160722
14. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94. doi:10.7326/0003-4819-134-8-200104170-00012
15. HurstV, Percie du SertN. The ARRIVE guidelines survey. Open science framework. 2017https://osf.io/g8t5q/register/565fb3678c5e4a66b5582f67
16. Reichlin TS, Vogt L, Würbel H. The researchers' view of scientific rigor-survey on the conduct and reporting of in vivo research. PLoS One 2016;11:e0165999. doi:10.1371/journal.pone.0165999
17. Landis SC, Amara SG, Asadullah K, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012;490:187-91. doi:10.1038/nature11556
18. McNutt M. Journals unite for reproducibility. Science 2014;346:679. doi:10.1126/science.aaa1724
19. Announcement: reducing our irreproducibility. Nature 2013;496. doi:10.1038/496398a
20. Marcus E. A STAR is born. Cell 2016;166:1059-60. doi:10.1016/j.cell.2016.08.021
21. Curtis MJ, Bond RA, Spina D, et al. Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 2015;172:3461-71. doi:10.1111/bph.12856
22. Mogil JS, Macleod MR. No publication without confirmation. Nature 2017;542:409-11. doi:10.1038/542409a
23. Kimmelman J, Mogil JS, Dirnagl U. Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol 2014;12:e1001863. doi:10.1371/journal.pbio.1001863